Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (690)	12/21/1999 8:20:00 PM
From: Jim Oravetz	Read Replies (1) \| Respond to of 783

Slight uptick in volume today, IMHO, indicates some tax loss selling (buy back after 30day wash period). I'm still bullish that this stock will be moving north in six months. The $ coming out of asia should start showing up by then. Jim

To: JDN who wrote (690)	12/29/1999 11:06:00 AM
From: tuck	Read Replies (1) \| Respond to of 783

JDN, I got called out of this stock this month, but I bought back in on the continued weakness. I now have a bigger position at ~20 1/2. My plan is to write January 22 1/2 calls in the next week. Then I'll hold to see what the end of January news is for BCHE. I don't know if you dabble in options, but it seems like a good way to lower your average cost to the current market price without much likelihood of sacrificing the coming upside, since the news will come out well after expiration. FWIW, The folks at the IMGN thread were hoping BCHE would announce an IND involving IMGN's technology at the recent conferences. If their expectations can be taken as a fair proxy for the Street's, that might explain why BCHE is still weak, since no such announcements were made. Cheers, Tuck